Literature DB >> 2062806

Racial differences in drug response: isoproterenol effects before and after propranolol.

D R Rutledge1, A Wallace, J D Steinberg, L Cardozo, S J Lavine.   

Abstract

The aim of this study was to determine in young, healthy men the relative contribution of pharmacodynamic factors inherent between two groups known to respond differently to hypertensive therapy. Black (n = 10) and white (n = 10) men received an isoproterenol sensitivity test before and after propranolol (0.1 mg/kg, then 50 micrograms/min). There were greater increases (twofold) in systolic BP following the 1.0- and 1.5-microgram isoproterenol dose (P less than 0.05) in the black group. During propranolol there were no differences in free (1)-propranolol concentrations between the groups; however, propranolol decreased resting heart rate in the white group more than in the black group (P less than 0.05). Cardiac index decreased less in the black group compared to the white group (P less than 0.05). Following the second isoproterenol challenge, there again were greater increases in systolic BP in the black group at both the 10- and the 20-micrograms isoproterenol dose (P less than 0.05). Our study has highlighted the importance of cross-racial studies in evaluating drug effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062806     DOI: 10.1023/a:1015806202180

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  THE EYE OF THE WEST AFRICAN NEGRO.

Authors:  J G Scott
Journal:  Br J Ophthalmol       Date:  1945-01       Impact factor: 4.638

2.  Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites.

Authors:  H H Zhou; R P Koshakji; D J Silberstein; G R Wilkinson; A J Wood
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

3.  Racial differences in drug response: isoproterenol effects on heart rate in healthy males.

Authors:  D R Rutledge; L Cardozo; J D Steinberg
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

4.  Racial differences in drug response: isoproterenol effects on heart rate following intravenous metoprolol.

Authors:  D R Rutledge; J Steinberg; L Cardozo
Journal:  Clin Pharmacol Ther       Date:  1989-04       Impact factor: 6.875

5.  Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis.

Authors:  J D Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

6.  Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in man.

Authors:  H H Vincent; A J Man In't Veld; F Boomsma; G J Wenting; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

7.  Trial of atenolol and chlorthalidone for hypertension in black South Africans.

Authors:  Y K Seedat
Journal:  Br Med J       Date:  1980-11-08

8.  Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man.

Authors:  C Von Bahr; J Hermansson; K Tawara
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

9.  Rapid high-performance liquid chromatographic method for the measurement of the enantiomers of metoprolol in serum using a chiral stationary phase.

Authors:  D R Rutledge; C Garrick
Journal:  J Chromatogr       Date:  1989-12-29

10.  Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.

Authors: 
Journal:  Am J Cardiol       Date:  1983-12-01       Impact factor: 2.778

View more
  1 in total

Review 1.  Race and hypertension. What is clinically relevant?

Authors:  D R Rutledge
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.